HCTI · Healthcare Triangle, Inc.

Healthcare Triangle delivered revenue growth of 18.8% to $13.9 million in FY 2025 from $11.7 million in the prior year, primarily through adoption of solutions by new and existing customers and expanding software services to the customer base. This aligns with management's emphasis on increasing the customer base and cross-selling capabilities as key growth drivers. However, gross profit declined 34.6% to $1.9 million from $2.9 million, compressing the gross margin to 13.6%. This erosion reflects challenges in the revenue mix, particularly from fulfilling service obligations under Statements of Work (SOW) that may carry lower margins, highlighting the importance of solution mix to success.

Operating results deteriorated significantly, with operating income falling 106.0% to a loss of $9.8 million from $4.8 million, yielding an operating margin of -70.5%. The deeper losses stem from costs outpacing revenue gains during the public company scaling phase, consistent with expectations that general and administrative expenses will rise to support business growth. Net income followed suit, widening 58.8% to a $9.5 million loss from $6.0 million, while diluted EPS cratered to -$152.30 from -$1.13, largely due to share dilution from equity issuances used to finance operations.

Cash flow dynamics underscore liquidity pressures, as net cash used in operating activities ballooned to $16.5 million from $1.1 million, with free cash flow at -$16.5 million after minimal $6,000 in capital expenditures. The company has historically financed operations primarily through financing activities rather than sustainable operating cash flows, amplifying dependence on external capital. Management acknowledges these challenges and is actively pursuing additional liquidity sources while prioritizing revenue growth, expense management, and working capital optimization to enhance operating performance.

Depreciation and amortization expenses, tied to fixed assets, customer relationships, software costs, and IP technology, contribute to the cost structure alongside other income/expense items like finance costs and foreign currency fluctuations. Looking ahead, the healthcare and EHR sectors face ongoing regulatory changes that could impact results, emphasizing the need for strategic focus on higher-margin opportunities and customer diversification to mitigate risks and restore profitability.